Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive models of adverse outcomes of overweight or obesity: a nationwide cohort validation.

BMC endocrine disorders·2026
Same author

AI-based detection of coronary artery calcium score in non-gated chest computed tomography of patients who decline statin therapy: A missed opportunity for prevention.

Journal of cardiovascular computed tomography·2026
Same author

Cumulative excess weight exposure over time and cardiovascular risk: A prospective cohort study.

PloS one·2026
Same author

Cardiovascular Events in Individuals Treated With Sulfonylureas or Dipeptidyl Peptidase 4 Inhibitors.

JAMA network open·2025
Same author

An Unusual Presentation of Bullous Skin Lesions During Pregnancy.

Journal of investigative medicine high impact case reports·2025
Same author

Reasons for non-acceptance of statin therapy by patients at high cardiovascular risk.

Scientific reports·2025

Related Experiment Video

Updated: May 12, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Statin use and calcific uremic arteriolopathy: a matched case-control study.

Sagar U Nigwekar1, Ishir Bhan, Alexander Turchin

  • 1Division of Nephrology, Dermatopathology Unit, Massachusetts General Hospital, Boston, MA 02114, USA. sagarnigs@gmail.com

American Journal of Nephrology
|April 4, 2013
PubMed
Summary

Statin use may reduce the risk of calcific uremic arteriolopathy (CUA), a serious vascular condition in dialysis patients. Further research is needed to confirm this protective association.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Experiment Videos

Last Updated: May 12, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
05:47

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro

Published on: May 10, 2021

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Area of Science:

  • Nephrology
  • Vascular Biology
  • Pharmacology

Background:

  • Calcific uremic arteriolopathy (CUA), or calciphylaxis, involves vascular calcification, thrombosis, and inflammation.
  • Statins possess anticalcification, antithrombotic, and anti-inflammatory properties.
  • The association between statin use and CUA has not been previously investigated.

Purpose of the Study:

  • To investigate the association between statin use and the occurrence of calcific uremic arteriolopathy (CUA) in maintenance hemodialysis patients.

Main Methods:

  • A matched case-control study involving 62 biopsy-confirmed CUA patients (cases) and 124 controls, all maintenance hemodialysis patients.
  • Patients were matched by gender and hospitalization timing.
  • Logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) for CUA in statin users.

Main Results:

  • Statin use was less common in CUA cases (19%) compared to controls (39%), with a statistically significant association (p < 0.01).
  • Statin use was associated with significantly lower odds of CUA in both unadjusted (OR 0.38) and adjusted (OR 0.20) analyses.
  • Hypercalcemia, hypoalbuminemia, calcitriol, and warfarin use were positively associated with CUA, while certain vitamin D analogs were not.

Conclusions:

  • Statin use may be negatively associated with the odds of developing calcific uremic arteriolopathy (CUA).
  • Further large prospective studies are required to validate these findings and explore potential confounding factors.